"Tuberculosis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.
| Descriptor ID |
D032581
|
| MeSH Number(s) |
D20.215.894.135.825
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis Vaccines".
This graph shows the total number of publications written about "Tuberculosis Vaccines" by people in this website by year, and whether "Tuberculosis Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tuberculosis Vaccines" by people in Profiles.
-
Mycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs. Nat Commun. 2024 Jun 27; 15(1):5467.
-
Prenatal and early-life exposure to the Great Chinese Famine increased the risk of tuberculosis in adulthood across two generations. Proc Natl Acad Sci U S A. 2020 11 03; 117(44):27549-27555.
-
Evaluation of Peripheral Blood Markers as Early Endpoint Criteria in Guinea Pigs (Cavia porcellus) when Testing Tuberculosis Vaccine Candidates. Comp Med. 2020 02 01; 70(1):45-55.
-
Pharmaceutical aerosols for the treatment and prevention of tuberculosis. Front Cell Infect Microbiol. 2012; 2:118.
-
Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines. AAPS J. 2009 Mar; 11(1):139-47.
-
Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. Pharm Res. 2007 Oct; 24(10):1834-43.